Subscribe to RSS
DOI: 10.1055/s-0039-1698459
Short-Term Complications Associated with Surgical Ligation of Patent Ductus Arteriosus in ELBW Infants: A 25-Year Cohort Study
Funding None.![](https://www.thieme-connect.de/media/ajp/202105/lookinside/thumbnails/10-1055-s-0039-1698459_190260-1.jpg)
Abstract
Objective This article aims to determine the incidence of short-term complications of surgical patent ductus arteriosus (PDA) ligations, the factors associated with those complications, and whether complications are associated with poor long-term outcomes.
Study Design Retrospective cohort study of all extremely low birth weight (ELBW, < 1,000 g) infants who underwent surgical PDA ligation at a single-center neonatal intensive care unit from 1989 to 2015. Demographic, clinical, and laboratory data were reviewed. The primary outcome was development of a short-term (< 2 weeks from ligation) surgical complication. Secondary outcomes include bronchopulmonary dysplasia (BPD), length of stay, and mortality.
Results A total of 180 ELBW infants were included; median gestational age and birth weight was 24 weeks and 683 g, respectively, and 44% of infants had at least one short-term complication. Need for vasopressors (33%) was the most common medical complication and vocal cord paralysis (9%) was the most common surgical complication. Younger corrected gestational age at time of repair was associated with increased risk for complications. Mortality, length of stay, and BPD rates were similar between infants with and without complications.
Conclusion Serious complications were seen in a minority of infants. Additional research is needed to determine if short-term complications are associated with long-term adverse outcomes.
Publication History
Received: 07 May 2019
Accepted: 29 August 2019
Article published online:
04 November 2019
© 2019. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation 2006; 114 (17) 1873-1882
- 2 Mezu-Ndubuisi OJ, Agarwal G, Raghavan A, Pham JT, Ohler KH, Maheshwari A. Patent ductus arteriosus in premature neonates. Drugs 2012; 72 (07) 907-916
- 3 Sellmer A, Bjerre JV, Schmidt MR. et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch Dis Child Fetal Neonatal Ed 2013; 98 (06) F505-F510
- 4 Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983; 102 (06) 895-906
- 5 Noori S, McCoy M, Friedlich P. et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009; 123 (01) e138-e144
- 6 Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol 2001; 18 (01) 1-9
- 7 Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996; 75 (03) F183-F186
- 8 Alfaleh K, Smyth JA, Roberts RS, Solimano A, Asztalos EV, Schmidt B. Trial of Indomethacin Prophylaxis in Preterms Investigators. Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. Pediatrics 2008; 121 (02) e233-e238
- 9 Dollberg S, Lusky A, Reichman B. Israel Neonatal Network. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr 2005; 40 (02) 184-188
- 10 Higgins RD, Mendelsohn AL, DeFeo MJ, Ucsel R, Hendricks-Munoz KD. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol 1998; 116 (05) 601-605
- 11 Hammerman C, Kaplan M. Comparative tolerability of pharmacological treatments for patent ductus arteriosus. Drug Saf 2001; 24 (07) 537-551
- 12 Lemmers PM, Toet MC, van Bel F. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants. Pediatrics 2008; 121 (01) 142-147
- 13 Janz-Robinson EM, Badawi N, Walker K, Bajuk B, Abdel-Latif ME. Neonatal Intensive Care Units Network. Neurodevelopmental outcomes of premature infants treated for patent ductus arteriosus: a population-based cohort study. J Pediatr 2015; 167 (05) 1025-1032
- 14 Sung SI, Chang YS, Chun JY. et al. Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants. J Pediatr 2016; 177: 66-71
- 15 Madan JC, Kendrick D, Hagadorn JI, Frantz III ID. National Institute of Child Health and Human Development Neonatal Research Network. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics 2009; 123 (02) 674-681
- 16 Bourgoin L, Cipierre C, Hauet Q. et al. Neurodevelopmental outcome at 2 years of age according to patent ductus arteriosus management in very preterm infants. Neonatology 2016; 109 (02) 139-146
- 17 Härkin P, Marttila R, Pokka T, Saarela T, Hallman M. Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study. J Matern Fetal Neonatal Med 2018; 31 (19) 2576-2583
- 18 Fowlie PW, Davis PG, McGuire W. Cochrane Review: prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Evid Based Child Health 2010; 5 (01) 416-471
- 19 Van Overmeire B, Allegaert K, Casaer A. et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004; 364 (9449): 1945-1949
- 20 Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2011; 7 (07) CD004213
- 21 Sperandio M, Beedgen B, Feneberg R. et al. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation. Pediatrics 2005; 116 (06) 1361-1366
- 22 Palder SB, Schwartz MZ, Tyson KR, Marr CC. Management of patent ductus arteriosus: a comparison of operative v pharmacologic treatment. J Pediatr Surg 1987; 22 (12) 1171-1174
- 23 Perez CA, Bustorff-Silva JM, Villasenor E, Fonkalsrud EW, Atkinson JB. Surgical ligation of patent ductus arteriosus in very low birth weight infants: is it safe?. Am Surg 1998; 64 (10) 1007-1009
- 24 Rudd P, Montanez P, Hallidie-Smith K, Silverman M. Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial. Arch Dis Child 1983; 58 (04) 267-270
- 25 Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 1978; 93 (04) 647-651
- 26 Niinikoski H, Alanen M, Parvinen T, Aantaa R, Ekblad H, Kero P. Surgical closure of patent ductus arteriosus in very-low-birth-weight infants. Pediatr Surg Int 2001; 17 (5-6): 338-341
- 27 Ekici F, Atasay B, Günlemez A. et al. Management of patent ductus arteriosus in preterm infants. Anadolu Kardiyol Derg 2006; 6 (01) 28-33
- 28 Harting MT, Blakely ML, Cox Jr CS, Lantin-Hermoso R, Andrassy RJ, Lally KP. Acute hemodynamic decompensation following patent ductus arteriosus ligation in premature infants. J Invest Surg 2008; 21 (03) 133-138
- 29 Moin F, Kennedy KA, Moya FR. Risk factors predicting vasopressor use after patent ductus arteriosus ligation. Am J Perinatol 2003; 20 (06) 313-320
- 30 McNamara PJ, Stewart L, Shivananda SP, Stephens D, Sehgal A. Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000 g. J Thorac Cardiovasc Surg 2010; 140 (01) 150-157
- 31 Malcolm WF, Hornik C, Evans A, Smith PB, Cotten CM. Vocal fold paralysis following surgical ductal closure in extremely low birth weight infants: a case series of feeding and respiratory complications. J Perinatol 2008; 28 (11) 782-785
- 32 Pereira KD, Webb BD, Blakely ML, Cox Jr CS, Lally KP. Sequelae of recurrent laryngeal nerve injury after patent ductus arteriosus ligation. Int J Pediatr Otorhinolaryngol 2006; 70 (09) 1609-1612
- 33 Rukholm G, Farrokhyar F, Reid D. Vocal cord paralysis post patent ductus arteriosus ligation surgery: risks and co-morbidities. Int J Pediatr Otorhinolaryngol 2012; 76 (11) 1637-1641
- 34 Smith ME, King JD, Elsherif A, Muntz HR, Park AH, Kouretas PC. Should all newborns who undergo patent ductus arteriosus ligation be examined for vocal fold mobility?. Laryngoscope 2009; 119 (08) 1606-1609
- 35 Spanos WC, Brookes JT, Smith MC, Burkhart HM, Bell EF, Smith RJ. Unilateral vocal fold paralysis in premature infants after ligation of patent ductus arteriosus: vascular clip versus suture ligature. Ann Otol Rhinol Laryngol 2009; 118 (10) 750-753
- 36 Zbar RI, Chen AH, Behrendt DM, Bell EF, Smith RJ. Incidence of vocal fold paralysis in infants undergoing ligation of patent ductus arteriosus. Ann Thorac Surg 1996; 61 (03) 814-816
- 37 Nezafati MH, Soltani G, Vedadian A. Video-assisted ductal closure with new modifications: minimally invasive, maximally effective, 1,300 cases. Ann Thorac Surg 2007; 84 (04) 1343-1348
- 38 Harris LL, Krishnamurthy R, Browne LP, Morales DLS, Friedman EM. Left main bronchus obstruction after patent ductus arteriosus ligation: an unusual complication. Int J Pediatr Otorhinolaryngol 2012; 76 (12) 1855-1856
- 39 Benjacholmas V, Namchaisiri J, Lertsarpcharoen P, Punnahitananda S, Thaithumyanon P. Short-term outcome of PDA ligation in the preterm infants at King Chulalongkorn Memorial Hospital, Thailand. J Med Assoc Thai 2009; 92 (07) 909-913
- 40 Hsu KH, Chiang MC, Lien R. et al. Diaphragmatic paralysis among very low birth weight infants following ligation for patent ductus arteriosus. Eur J Pediatr 2012; 171 (11) 1639-1644
- 41 Kang SL, Samsudin S, Kuruvilla M, Dhelaria A, Kent S, Kelsall WA. Outcome of patent ductus arteriosus ligation in premature infants in the East of England: a prospective cohort study. Cardiol Young 2013; 23 (05) 711-716
- 42 Chiang MC, Lin WS, Lien R, Chou YH. Reexpansion pulmonary edema following patent ductus arteriosus ligation in a preterm infant. J Perinat Med 2004; 32 (04) 365-367
- 43 Grasser M, Döhlemann C, Mittal R. et al. Acquired heart block: a possible complication of patent ductus arteriosus in a preterm infant. Neonatology 2008; 93 (04) 276-280
- 44 Benjamin JR, Smith PB, Cotten CM, Jaggers J, Goldstein RF, Malcolm WF. Long-term morbidities associated with vocal cord paralysis after surgical closure of a patent ductus arteriosus in extremely low birth weight infants. J Perinatol 2010; 30 (06) 408-413
- 45 Ko YC, Chang CI, Chiu S, Chen YS, Huang SC, Hsieh WS. Surgical ligation of patent ductus arteriosus in very-low-birth-weight premature infants in the NICU. J Formos Med Assoc 2009; 108 (01) 69-71
- 46 Gould DS, Montenegro LM, Gaynor JW. et al. A comparison of on-site and off-site patent ductus arteriosus ligation in premature infants. Pediatrics 2003; 112 (6 Pt 1): 1298-1301
- 47 Mandhan P, Brown S, Kukkady A, Samarakkody U. Surgical closure of patent ductus arteriosus in preterm low birth weight infants. Congenit Heart Dis 2009; 4 (01) 34-37
- 48 Clement WA, El-Hakim H, Phillipos EZ, Coté JJ. Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weight infants. Arch Otolaryngol Head Neck Surg 2008; 134 (01) 28-33
- 49 Burke RP, Jacobs JP, Cheng W, Trento A, Fontana GP. Video-assisted thoracoscopic surgery for patent ductus arteriosus in low birth weight neonates and infants. Pediatrics 1999; 104 (2 Pt 1): 227-230
- 50 Wagner HR, Ellison RC, Zierler S. et al. Surgical closure of patent ductus arteriosus in 268 preterm infants. J Thorac Cardiovasc Surg 1984; 87 (06) 870-875